OL
MRNA icon

Optas LLC’s Moderna MRNA Stock Holding History

Optas LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
+3,640
New +$188K 0.04% 377
2021
Q4 		– Sell
-970
Closed -$373K – 155
2021
Q3 		$373K Sell
970
-104
-10% -$38.4K 0.11% 104
2021
Q2 		$252K Buy
+1,074
New +$192K 0.07% 125

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Optas LLC's MRNA Position: Q2 2026 in Review

Optas LLC opened a new position in Moderna (MRNA) in Q2 2026: 3,640 shares worth $255K. The stake represents 0.04% of the portfolio and ranks #377 among its holdings. This is a return to the name: Optas LLC previously reported a position in MRNA as recently as Q3 2021.

Optas LLC first reported a position in MRNA in Q2 2021 and has held it in 3 quarters since. The position peaked at $373K in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Optas LLC held 3,640 shares of Moderna worth $255K as of Q2 2026.
  • Moderna was a new Optas LLC position in Q2 2026.
  • Moderna made up 0.04% of Optas LLC's portfolio in Q2 2026, its #377 holding.
  • Optas LLC first reported a position in Moderna in Q2 2021 and has held it in 3 quarters since.
  • Optas LLC's Moderna position peaked at $373K in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.